TreQ Unveils Compass SG25B: The Open-Architecture Quantum Innovation Station
Builds a Faster Path to Quantum Research & Development with Industry-Leading Partners
ANAHEIM, CA, UNITED STATES, March 17, 2025 / EINPresswire.com / -- TreQ, the quantum systems engineering and manufacturing company, today announces the launch of the Compass SG25B to break down the barriers to quantum innovation. A turnkey, open-architecture quantum computing system, Compass SG25B is designed for researchers and developers eager to move their work forward without the bottlenecks of infrastructure logistics.
Built with extensibility, upgradability, and low-level access in mind, Compass SG25B enables quantum pioneers to push the boundaries of discovery, while leveraging the expertise of industry-leading quantum technology providers including Rigetti Computing, Qblox, QuantrolOx, and Bluefors.
'Quantum computing development shouldn't be held back by supply chain challenges or closed architectures,' said Mandy Birch, CEO, TreQ. 'Compass SG25B is an innovation station built for explorers. The open-architecture system frees researchers to focus on breakthroughs instead of lab infrastructure. With this launch, we're not just delivering hardware; we're delivering momentum.'
Built from an Emerging Quantum Supply Chain
TreQ's Compass SG25B is the result of innovations across the quantum ecosystem:
- Rigetti Computing provides the Novera™ 9-qubit processor, built with the same Ankaa™-class architecture powering its larger-scale quantum systems.
- Qblox delivers a modular control stack, designed to grow with evolving quantum research needs.
- QuantrolOx provides Quantum EDGE, an advanced qubit automation platform streamlining tuning and calibration.
- Bluefors contributes its Ultra-Compact LD dilution refrigerator, ensuring seamless integration of cooling and cryogenic control in a space-efficient design.
During a successful integration and test demonstration in February, the system met its target performance specifications. Today, the Compass SG25B is available for worldwide deployment, providing researchers with a fully realized, turnkey, open-architecture quantum computing system.
TreQ's supply chain partners emphasize the strategic importance of open, accessible quantum systems:
'Open architecture unlocks innovative and creative solutions to the challenges posed by the transformative power of quantum computing. Rigetti's Novera QPU brings high-fidelity quantum operations to Compass SG25B, enabling researchers to explore and innovate with confidence.'
— Dr. Subodh Kulkarni, CEO, Rigetti
'The flexibility of open architecture is essential for establishing the breakthroughs required towards industrial-scale quantum computers. Qblox Cluster is the platform to bring out the best in SG25B in terms of speed to results, optimal fidelity and is ready to scale with the needs of its users.'
— Niels Bultink, CEO, Qblox
'With QuantrolOx Quantum EDGE, researchers can automate and optimize their quantum experiments, accelerating time to results.'
— Vishal Chatrath, CEO, QuantrolOx
'The Bluefors Ultra-Compact LD is engineered for efficiency and integration, making Compass SG25B a smart choice for labs that need seamless, high-performance cooling.'
—Mikko Nurminen, CSO, Bluefors
Infrastructure to Bring Research to the Forefront
Compass SG25B is upgradeable and engineered for flexibility, ensuring institutions and enterprises can stay ahead with capital efficiency in the rapidly evolving quantum landscape.
TreQ is currently accepting bids for 2025 and 2026 reference sites. To be among the first to host an open-architecture quantum system, visit treq.tech/event/20250317pr or contact Gibson Armstrong at [email protected].
About TreQ
TreQ is a global quantum systems engineering and manufacturing company building and operating bespoke, open-architecture quantum computing clusters.
Josie Fellows
TFD - Think Feel Do
Legal Disclaimer:
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 hours ago
- Yahoo
Nucor Corporation (NUE): A Bull Case Theory
We came across a bullish thesis on Nucor Corporation (NUE) on Business Model Mastery's Substack. In this article, we will summarize the bulls' thesis on NUE. Nucor Corporation (NUE)'s share was trading at $108.94 as of 29th May. NUE's trailing and forward P/E were 19.20 and 14.14 respectively according to Yahoo Finance. A steel rod, bent and contoured to the exact specifications of the company. Nucor stands out as a vertically integrated steel producer operating through three synergistic segments—steel mills, steel products, and raw materials—underpinned by its control of critical inputs, including 3.5 million metric tons of direct reduced iron (DRI) and 18 million tons of recycled scrap annually. This integration enables tight cost control and reliable supply chains. The company's strategic focus on high-value products like insulated panels, overhead doors, and custom racking systems has driven meaningful margin expansion, further bolstered by premium-branded offerings such as ECONIQ™ and AEOS™, which meet growing demand in low-carbon and seismic-resistant construction markets. Nucor's operational flexibility is a core strength, with nearly all production relying on electric arc furnaces (EAFs) that offer rapid scalability and deliver 60–70% lower carbon emissions compared to traditional blast furnaces. Its micro mill strategy and regional footprint enhance both cost efficiency and environmental performance. The company's unique decentralized culture, with just 200 employees at headquarters overseeing over 32,000 teammates, empowers plant-level decision-making and incentivizes performance, driving innovation and responsiveness. This structure supports its aggressive capex-driven growth strategy—$11.8 billion deployed over the past three years, with 63% allocated to capacity expansion and 37% to acquisitions. These investments target fast-growing sectors such as data centers, renewable energy, and automated warehousing, positioning Nucor for long-term structural advantage. The company's integrated model, flexible operations, and disciplined capital deployment collectively support a compelling narrative of margin growth, sustainable production leadership, and strategic evolution in key demand verticals. For a comprehensive analysis of another standout stock covered by the same author, we recommend reading our summary of their of Sanofi (SNY). Since our coverage, the stock is up 4.7%. Nucor Corporation (NUE) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 51 hedge fund portfolios held NUE at the end of the first quarter which was 50 in the previous quarter. While we acknowledge the potential of NUE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
18 hours ago
- Yahoo
Nanalysis Announces Fully Subscribed $2 Million Note Offering
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ CALGARY, AB, June 6, 2025 /CNW/ - Nanalysis Scientific Corp. (the "Company" or "Nanalysis") (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), is pleased to announce that its previously disclosed offering of 12% unsecured promissory notes (the "Notes") for aggregate gross proceeds of $2,000,000 (the "Offering") is now fully subscribed. As part of the Offering, the Company will issue an aggregate of 1,600,000 bonus common shares to subscribers. These shares will be subject to a four month hold period commencing from the date of issuance thereof, in accordance with applicable securities laws. Closing of the Offering is scheduled to occur on or about June 11, 2025, and remains subject to customary closing conditions, including receipt of all necessary corporate and regulatory approvals, including TSX Venture Exchange ("TSXV") acceptance. For further information regarding the Offering, please refer to the Company's news release dated June 6, 2025, available on SEDAR+ at About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) Nanalysis Scientific Corp. in operates two primary business segments: Scientific Equipment and Security Services. Within its Scientific Equipment business is what the Company terms "MRI and NMR for industry". The Company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The Company has followed up that initial offering with new products and continues to have a strong innovation pipeline. In 2020, the Company announced the launch of its 100MHz platform, which has the highest usable field on a fully featured benchtop NMR on the market. In early 2025, the Company launched its new 60MHz instrument which is based on the successful 100MHz product line. The Company's devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company is working to expand into new global market opportunities independently and with partners. With its partners, the Company provides scientific equipment sales and maintenance services globally. Within the Company's Security Services business, the core activity is providing airport security equipment maintenance in each province and territory of Canada. In addition, the Company provides commercial security equipment installation and maintenance services to a variety of customers in North America. Notice regarding Forward Looking Information and Legal Disclaimer This news release contains certain forward-looking information. All statements included herein, other than statements of historical fact, are forward-looking information and such information involves various risks and uncertainties. In particular, this news release contains forward-looking information in relation to: closing of the Offering; TSXV approval of the Notes and issuance of Bonus Shares; the use of proceeds of the Offering; payment of interest on the Notes in cash or common shares, subject to TSXV approval; the Company's payment of finder's fees in connection with the Offering; and investor participation in the Offering. There can be no assurance that such information will prove to be accurate, and actual results and future events could differ materially from those anticipated in such information. This forward-looking information reflects Nanalysis's current beliefs and is based on information currently available to Nanalysis and on assumptions Nanalysis believes are reasonable. These assumptions include, but are not limited to: the current share price of Nanalysis's common shares; TSXV acceptance and market acceptance of the offering; Nanalysis' general and administrative costs remaining constant; and market acceptance of Nanalysis's business model, goals and approach. Forward-looking information is subject to known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Nanalysis to be materially different from those expressed or implied by such forward-looking information. Statements with forward looking information are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Readers should not place undue reliance on forward-looking information. Nanalysis does not undertake to update any forward-looking information except in accordance with applicable securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws, unless an exemption from such registration is available. Neither the TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. SOURCE Nanalysis Scientific Corp. View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
18 hours ago
- Yahoo
Enovis to Participate in Upcoming Investor Conferences
Wilmington, DE, June 06, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences: Goldman Sachs 46th Annual Global Healthcare Conference: Ben Berry, Chief Financial Officer, will participate in a fireside chat on Tuesday, June 10th at 2:00 p.m. Eastern Time. Citizens Medical Devices and Healthcare Services Forum: Ben Berry, Chief Financial Officer, will participate in investor meetings on Tuesday, June 17th. A link to the live audio webcasts, if available, as well as a replay of these events, will be available on the Company's website under the Investors tab at Events and Presentations. ABOUT ENOVIS Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company's extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company's shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit Contact: Kyle RoseVice President, Investor RelationsEnovis Corporationinvestorrelations@
